On February 2, 2004, investigative reporter, Kelly O'Meara, wrote an article that reported on the first clinical trial of its kind, by Dr David Healy, director of the North Wales Department of Psychological Medicine at the University of Wales, in which Prozac was given to a volunteer group of mentally healthy adults.
The study determined, apparently just as in the case of Ms Hurcombe's "undepressed" daughter, that even mentally healthy adults were adversely affected by the drug.
According to Ms O'Meara, between one in 20, and one in 10, people in the study on Prozac experienced akathisia, "whereby they become mentally restless or manic and lose all inhibitions about their actions."
"People don't care about the consequences as you'd normally expect," Dr Healy explains, "they're not bothered about contemplating something they would usually be scared of."
He said the study showed that: "We can make healthy volunteers belligerent, fearful, suicidal, and even pose a risk to others."
Kelly O'Meara's coverage of the adverse effects of psychiatric drugs is virtually unmatched by any other journalist in the US. During her 6-year stint with the Washington Times' Insight magazine, she wrote more than two dozen investigative articles about the link between SSRIs and the bizarre, violent acts committed by patients taking the drugs, which include the majority of children involved in school shootings in the US.
Her new book, "Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill," is about informed consent. "The people need and deserve the whole truth about their psychiatric diagnosis," Ms O'Meara advises, "and the mind-altering drugs that are prescribed as treatment."
Experts say the book is a must read for patients considering whether to take psychiatric drugs. The "chemical imbalance in the brain" theory that drug maker's tell patients they have when marketing the drugs, is debunked in the book by some of the nation's leading experts, and according to Ms O'Meara, the drug companies themselves have been forced to admit that they do not understand how the drugs work in the human brain during the treatment of an alleged mental illness.
"In fact," she says, "a test that measures a person's brain chemicals does not exist."
"Never in the history of the world has science discovered what the correct brain chemical levels are for any living person," Ms O'Meara explains, "making it impossible to know if these naturally occurring chemicals are out of balance."
"If confirmable proof of a chemical imbalance were required prior to filling a prescription for any antidepressants," she says, "not a single prescription would be written because to date the only known method of determining chemical levels in the brain is during autopsy."
Over the last decade the drug companies have conned doctors into writing millions of prescriptions to children for these SSRIs, under the guise of protecting them from suicide, and yet the suicide rates for kids during this time period have remained statistically unchanged, with boys varying by at most one suicide up or down, and the rate for girls not moving an inch, according to a review of statistics put out by the Department of Health and Human Services.
Even though the atypical antipsychotics are not FDA approved for any use with children, and their package inserts specifically state that their safety and effectiveness with children have not been established, Big Pharma has doctors prescribing them off-label to children of all ages for a long list of so-called mental disorders.
According to a study in the March-April 2006, Ambulatory Pediatrics journal, between 1995 and 2002, the rate of children receiving antipsychotics increased five-fold, to an estimated 2.5 million, or an increase from 8.6 prescriptions for every 1,000 children in the mid-1990s, to nearly 40 in every 1,000 in 2002.
A recent review by USA Today of the FDA's adverse reporting system from 2000 to 2004, found at least 45 deaths in children under 18 listing atypicals as the "primary suspect." There were also an additional 1,328 reports of other side effects, including many that were life-threatening.
Other life-long physical adverse effects of these drugs are beginning to emerge in children. The Children's Hospital of Philadelphia recently found that 19% of newly diagnosed Type 2 diabetic children were being treated with atypical drugs, according to Robert F Kennedy Jr vs the Medical Elite, by Mark Sircus Ac, OMD, on June 22, 2005.
The study determined, apparently just as in the case of Ms Hurcombe's "undepressed" daughter, that even mentally healthy adults were adversely affected by the drug.
According to Ms O'Meara, between one in 20, and one in 10, people in the study on Prozac experienced akathisia, "whereby they become mentally restless or manic and lose all inhibitions about their actions."
"People don't care about the consequences as you'd normally expect," Dr Healy explains, "they're not bothered about contemplating something they would usually be scared of."
Kelly O'Meara's coverage of the adverse effects of psychiatric drugs is virtually unmatched by any other journalist in the US. During her 6-year stint with the Washington Times' Insight magazine, she wrote more than two dozen investigative articles about the link between SSRIs and the bizarre, violent acts committed by patients taking the drugs, which include the majority of children involved in school shootings in the US.
Her new book, "Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills That Kill," is about informed consent. "The people need and deserve the whole truth about their psychiatric diagnosis," Ms O'Meara advises, "and the mind-altering drugs that are prescribed as treatment."
Experts say the book is a must read for patients considering whether to take psychiatric drugs. The "chemical imbalance in the brain" theory that drug maker's tell patients they have when marketing the drugs, is debunked in the book by some of the nation's leading experts, and according to Ms O'Meara, the drug companies themselves have been forced to admit that they do not understand how the drugs work in the human brain during the treatment of an alleged mental illness.
"In fact," she says, "a test that measures a person's brain chemicals does not exist."
"Never in the history of the world has science discovered what the correct brain chemical levels are for any living person," Ms O'Meara explains, "making it impossible to know if these naturally occurring chemicals are out of balance."
"If confirmable proof of a chemical imbalance were required prior to filling a prescription for any antidepressants," she says, "not a single prescription would be written because to date the only known method of determining chemical levels in the brain is during autopsy."
Over the last decade the drug companies have conned doctors into writing millions of prescriptions to children for these SSRIs, under the guise of protecting them from suicide, and yet the suicide rates for kids during this time period have remained statistically unchanged, with boys varying by at most one suicide up or down, and the rate for girls not moving an inch, according to a review of statistics put out by the Department of Health and Human Services.
Even though the atypical antipsychotics are not FDA approved for any use with children, and their package inserts specifically state that their safety and effectiveness with children have not been established, Big Pharma has doctors prescribing them off-label to children of all ages for a long list of so-called mental disorders.
According to a study in the March-April 2006, Ambulatory Pediatrics journal, between 1995 and 2002, the rate of children receiving antipsychotics increased five-fold, to an estimated 2.5 million, or an increase from 8.6 prescriptions for every 1,000 children in the mid-1990s, to nearly 40 in every 1,000 in 2002.
A recent review by USA Today of the FDA's adverse reporting system from 2000 to 2004, found at least 45 deaths in children under 18 listing atypicals as the "primary suspect." There were also an additional 1,328 reports of other side effects, including many that were life-threatening.
Other life-long physical adverse effects of these drugs are beginning to emerge in children. The Children's Hospital of Philadelphia recently found that 19% of newly diagnosed Type 2 diabetic children were being treated with atypical drugs, according to Robert F Kennedy Jr vs the Medical Elite, by Mark Sircus Ac, OMD, on June 22, 2005.
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
